Breaking News Instant updates and real-time market news.

SEDG

SolarEdge

$81.48 /

-0.92 (-1.12%)

07:39
12/02/19
12/02
07:39
12/02/19
07:39

SolarEdge initiated with a Buy at Needham

Needham analyst James Ricchiuti initiated coverage of SolarEdge with a Buy rating and $102 price target. The analyst notes that this solar power component leader has a "bright outlook" and expects the company to benefit next year amid the "growing product roadmap and expanded supply chain outside of China". Ricchiuti also cites SolarEdge Technologies having started to diversify its business into adjacent markets with good growth potential and its long-term strategy of building a reputation as a "premier" smart energy company.

  • 02

    Dec

  • 03

    Dec

SEDG SolarEdge
$81.48 /

-0.92 (-1.12%)

12/02/19 Needham
SolarEdge initiated with a Buy at Needham
11/25/19 Roth Capital
SolarEdge price target lowered to $100 from $105 at Roth Capital
11/25/19
SolarEdge to host investor & analyst day
11/04/19 Canaccord
SolarEdge price target raised to $88 from $78 at Canaccord

TODAY'S FREE FLY STORIES

Initiation
Intuit initiated with an Overweight at Piper Sandler » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
INTU

Intuit

$307.15 /

-6.325 (-2.02%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

08/27/20 Argus
Intuit price target raised to $400 from $325 at Argus
08/26/20 RBC Capital
Intuit price target raised to $405 from $315 at RBC Capital
08/26/20 Oppenheimer
Intuit price target raised to $355 from $308 at Oppenheimer
08/26/20 Guggenheim
Intuit price target raised to $395 from $320 at Guggenheim
INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

INTU Intuit
$307.15 /

-6.325 (-2.02%)

Hot Stocks
PG&E CFO Jason Wells resigns to become CFO of another utility » 06:07
09/18/20
09/18
06:07
09/18/20
06:07
PCG

PG&E

$9.79 /

-0.02 (-0.20%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

08/03/20 Mizuho
PG&E price target raised to $14.50 from $13.50 at Mizuho
07/28/20 Citi
PG&E shares look inexpensive into wildfire season, says Citi
07/26/20 Goldman Sachs
PG&E resumed with a Buy at Goldman Sachs
07/09/20 Mizuho
PG&E trading at 56% price-to-earnings discount, says Mizuho
PCG PG&E
$9.79 /

-0.02 (-0.20%)

  • 26
    Jun
PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

PCG PG&E
$9.79 /

-0.02 (-0.20%)

Initiation
BioLife Solutions initiated with an Outperform at Cowen » 06:06
09/18/20
09/18
06:06
09/18/20
06:06
BLFS

BioLife Solutions

$25.38 /

-0.42 (-1.63%)

Cowen analyst Chris Lin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

08/11/20 Benchmark
BioLife Solutions downgraded at Benchmark as shares reach price target
08/11/20 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
07/08/20 Northland
BioLife Solutions price target raised to $28 from $24 at Northland
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

  • 02
    Jul
BLFS BioLife Solutions
$25.38 /

-0.42 (-1.63%)

Periodicals
SoftBank selling Brightstar to private equity firm, WSJ reports » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
SFTBY

SoftBank

$0.00 /

+ (+0.00%)

SoftBank is selling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
09/14/20 Deutsche Bank
ARM customers could push back on Nvidia deal, says Deutsche Bank
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

Hot Stocks
Power REIT acquires Maine property for cannabis processing » 06:05
09/18/20
09/18
06:05
09/18/20
06:05
PW

Power REIT

$17.91 /

-1.32 (-6.86%)

Power REIT announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PW Power REIT
$17.91 /

-1.32 (-6.86%)

Initiation
Epiroc initiated with a Buy at Berenberg » 06:03
09/18/20
09/18
06:03
09/18/20
06:03
EPOKY

Epiroc

$0.00 /

+ (+0.00%)

Berenberg analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPOKY Epiroc
$0.00 /

+ (+0.00%)

07/24/20 JPMorgan
Epiroc price target raised to SEK 115 from SEK 105 at JPMorgan
07/24/20 Deutsche Bank
Epiroc price target raised to SEK 120 from SEK 105 at Deutsche Bank
07/24/20 Credit Suisse
Epiroc price target raised to SEK 105 from SEK 88 at Credit Suisse
07/24/20 UBS
UBS backs Buy on Epiroc after Q2 results
Hot Stocks
Incyte says retifanlimab 'generally well-tolerated' in Phase 2 trial » 06:02
09/18/20
09/18
06:02
09/18/20
06:02
INCY

Incyte

$90.32 /

+0.39 (+0.43%)

Incyte announced results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

Periodicals
ByteDance, Oracle deal includes creation of oversight board, Axios reports » 06:01
09/18/20
09/18
06:01
09/18/20
06:01
ORCL

Oracle

$60.20 /

-0.23 (-0.38%)

An agreement between…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

ORCL Oracle
$60.20 /

-0.23 (-0.38%)

Downgrade
JPMorgan downgrades Beyond Meat to Underweight on 'sluggish' fundamentals » 06:01
09/18/20
09/18
06:01
09/18/20
06:01
BYND

Beyond Meat

$157.27 /

+0.49 (+0.31%)

JPMorgan analyst Ken…

JPMorgan analyst Ken Goldman downgraded Beyond Meat to Underweight from Neutral with an unchanged price target of $122. The shares closed Thursday up 65c to $157.22. The stock's 108% rally year-to-date is "above and beyond what we consider rational," even for a good company like Beyond Meat, Goldman tells investors in a research note. Street estimates look high with chief rival Impossible Foods taking market share at grocery and restaurants hesitating to add menu complexity during the COVID-19 crisis, adds the analyst. Goldman cites valuation and "sluggish fundamentals" for the downgrade.

ShowHide Related Items >><<
BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

04:44 Today JPMorgan
Beyond Meat downgraded to Underweight from Neutral at JPMorgan
09/15/20 Credit Suisse
Beyond Meat sales growth capped by near-term factors, says Credit Suisse
09/03/20
Fly Intel: Top five analyst initiations
09/02/20 Baird
Baird starts Beyond Meat at Outperform with $160 price target
BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

BYND Beyond Meat
$157.27 /

+0.49 (+0.31%)

Periodicals
JD.com's JD Health plans $1B Hong Kong IPO, Bloomberg reports » 05:59
09/18/20
09/18
05:59
09/18/20
05:59
JD

JD.com

$74.38 /

-0.68 (-0.91%)

, BAC

Bank of America

$25.35 /

-0.265 (-1.03%)

, UBS

UBS

$12.27 /

-0.075 (-0.61%)

JD Health, the online…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

08/24/20 Barclays
JD.com price target raised to $83 from $79 at Barclays
08/18/20
Fly Intel: Top five analyst upgrades
08/18/20 Susquehanna
JD.com price target raised to $70 from $55 at Susquehanna
08/18/20 Stifel
JD.com price target raised to $70 from $60 at Stifel
BAC Bank of America
$25.35 /

-0.265 (-1.03%)

09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Seaport Global
Bank of America initiated with a Neutral at Seaport Global
UBS UBS
$12.27 /

-0.075 (-0.61%)

07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
07/22/20 RBC Capital
UBS price target raised to CHF 12 from CHF 11 at RBC Capital
JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

UBS UBS
$12.27 /

-0.075 (-0.61%)

JD JD.com
$74.38 /

-0.68 (-0.91%)

BAC Bank of America
$25.35 /

-0.265 (-1.03%)

Hot Stocks
Ericsson acquires Cradlepoint in deal valued at 1.1B » 05:57
09/18/20
09/18
05:57
09/18/20
05:57
ERIC

Ericsson

$11.03 /

+0.165 (+1.52%)

Ericsson said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

08/26/20 Citi
Ericsson sell-side briefing supportive of positive thesis, says Citi
07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/20/20 JPMorgan
Ericsson price target raised to SEK 110 from SEK 104 at JPMorgan
07/20/20 Morgan Stanley
Ericsson price target raised to SEK 110 from SEK 100 at Morgan Stanley
ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

ERIC Ericsson
$11.03 /

+0.165 (+1.52%)

Hot Stocks
Genentech announces Phase III EMPACTA study met primary endpoint » 05:53
09/18/20
09/18
05:53
09/18/20
05:53
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares » 05:40
09/18/20
09/18
05:40
09/18/20
05:40
CAIXY

CaixaBank

$0.00 /

+ (+0.00%)

, BNKXF

Bankia

$0.00 /

+ (+0.00%)

The boards of Directors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

09/07/20 Berenberg
CaixaBank upgraded to Hold from Sell at Berenberg
08/07/20 AlphaValue
CaixaBank upgraded to Buy from Reduce at AlphaValue
08/03/20 Deutsche Bank
CaixaBank price target lowered to EUR 2.55 from EUR 2.60 at Deutsche Bank
08/03/20 Credit Suisse
CaixaBank positive investment thesis intact after Q2, says Credit Suisse
BNKXF Bankia
$0.00 /

+ (+0.00%)

09/16/20 Barclays
Bankia price target raised to EUR 1.30 from EUR 1.20 at Barclays
09/16/20 Citi
Bankia downgraded to Neutral from Buy at Citi
09/07/20 Berenberg
Bankia upgraded to Hold from Sell at Berenberg
09/04/20 Exane BNP Paribas
Bankia upgraded to Neutral from Underperform at Exane BNP Paribas
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

BNKXF Bankia
$0.00 /

+ (+0.00%)

Hot Stocks
NetEase announces ADS ratio change of five-for-one » 05:32
09/18/20
09/18
05:32
09/18/20
05:32
NTES

NetEase

$469.85 /

-4.44 (-0.94%)

NetEase announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

08/14/20 Barclays
NetEase price target raised to $530 from $500 at Barclays
08/14/20 Daiwa
NetEase initiated with a Buy at Daiwa
08/14/20 Benchmark
NetEase price target raised to $520 from $435 at Benchmark
07/27/20 Barclays
NetEase price target raised to $500 from $450 at Barclays
NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

NTES NetEase
$469.85 /

-4.44 (-0.94%)

Hot Stocks
Akcea Therapeutics receives NICE recommendation for volanesorsen » 05:27
09/18/20
09/18
05:27
09/18/20
05:27
AKCA

Akcea Therapeutics

$18.15 /

-0.005 (-0.03%)

Akcea Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

09/01/20 Oppenheimer
Ionis Pharmaceuticals price target lowered to $69 from $74 at Oppenheimer
08/31/20 BMO Capital
Akcea Therapeutics downgraded to Market Perform from Outperform at BMO Capital
08/31/20 Wells Fargo
Akcea Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/31/20 Piper Sandler
Piper Sandler sees Akcea consolidation as rational, cost 'appears minor'
AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

AKCA Akcea Therapeutics
$18.15 /

-0.005 (-0.03%)

Hot Stocks
Pfizer, EMD Serono announce publication of JAVELIN Bladder 100 study results » 05:20
09/18/20
09/18
05:20
09/18/20
05:20
PFE

Pfizer

$36.81 /

+0.02 (+0.05%)

EMD Serono and Pfizer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 JMP Securities
Trillium Therapeutics price target raised to $14 from $10 at JMP Securities
PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

PFE Pfizer
$36.81 /

+0.02 (+0.05%)

Hot Stocks
Apple brings online store to India September 23 » 05:20
09/18/20
09/18
05:20
09/18/20
05:20
AAPL

Apple

$110.35 /

-1.72 (-1.53%)

Apple said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

09/17/20 BWS Financial
AXT rumors of Apple win highlight value, says BWS Financial
09/17/20 Jefferies
Apple price target raised to $135 from $116.25 at Jefferies
09/16/20 B. Riley FBR
AXT Inc. shares may be overreacting to Apple Watch 6 news, says B. Riley FBR
09/16/20 Wedbush
Focus remains Apple iPhone 12 5G 'supercycle,' says Wedbush
AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

General news
FX Action: The is up on safe demand » 05:20
09/18/20
09/18
05:20
09/18/20
05:20

FX Action: The is up on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Zalando upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19
09/18/20
09/18
05:19
09/18/20
05:19
ZLNDY

Zalando

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZLNDY Zalando
$0.00 /

+ (+0.00%)

09/14/20 AlphaValue
Zalando upgraded to Add from Sell at AlphaValue
09/03/20 Barclays
Zalando price target raised to EUR 78.30 from EUR 65.50 at Barclays
08/31/20 Goldman Sachs
Zalando upgraded to Buy from Neutral at Goldman Sachs
08/12/20 RBC Capital
Zalando price target raised to EUR 80 from EUR 73 at RBC Capital
Hot Stocks
Regeneron, Sanofi present 'positive' data for Libtayo monotherapy in BCC » 05:19
09/18/20
09/18
05:19
09/18/20
05:19
REGN

Regeneron

$564.85 /

-4.15 (-0.73%)

, SNY

Sanofi

$52.08 /

+0.21 (+0.40%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
SNY Sanofi
$52.08 /

+0.21 (+0.40%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

  • 27
    May
REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

REGN Regeneron
$564.85 /

-4.15 (-0.73%)

SNY Sanofi
$52.08 /

+0.21 (+0.40%)

Downgrade
Novocure downgraded to Equal Weight from Overweight at Wells Fargo » 05:18
09/18/20
09/18
05:18
09/18/20
05:18
NVCR

Novocure

$108.96 /

+1.71 (+1.59%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
09/17/20 Truist
Novocure downgraded to Hold from Buy at Truist
09/17/20 Piper Sandler
Novocure price target raised to $125 from $89 at Piper Sandler
NVCR Novocure
$108.96 /

+1.71 (+1.59%)

NVCR Novocure
$108.96 /

+1.71 (+1.59%)

Upgrade
Winpak upgraded to Outperformer from Neutral at CIBC » 05:16
09/18/20
09/18
05:16
09/18/20
05:16
WIPKF

Winpak

$0.00 /

+ (+0.00%)

CIBC analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WIPKF Winpak
$0.00 /

+ (+0.00%)

05/06/20 TD Securities
Winpak price target raised to C$48 from C$45 at TD Securities
05/06/20 Scotiabank
Winpak price target raised to C$53 from C$51 at Scotiabank
05/06/20 RBC Capital
Winpak price target lowered to C$45 from C$46 at RBC Capital
Upgrade
Airports of Thailand upgraded to Outperform from Neutral at Macquarie » 05:16
09/18/20
09/18
05:16
09/18/20
05:16
AIPUY

Airports of Thailand

$0.00 /

+ (+0.00%)

Macquarie analyst Bo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIPUY Airports of Thailand
$0.00 /

+ (+0.00%)

08/03/20 Citi
Airports of Thailand downgraded to Sell from Buy at Citi
04/23/20 JPMorgan
Airports of Thailand downgraded to Underweight from Neutral at JPMorgan
Downgrade
Reliance Worldwide downgraded to Neutral from Buy at UBS » 05:15
09/18/20
09/18
05:15
09/18/20
05:15
RLLWF

Reliance Worldwide

$0.00 /

+ (+0.00%)

UBS downgraded Reliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Abeona Therapeutics initiated with a Buy at B. Riley FBR » 05:13
09/18/20
09/18
05:13
09/18/20
05:13
ABEO

Abeona Therapeutics

$1.96 /

+0.065 (+3.43%)

B. Riley FBR initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABEO Abeona Therapeutics
$1.96 /

+0.065 (+3.43%)

ABEO Abeona Therapeutics
$1.96 /

+0.065 (+3.43%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
ABEO Abeona Therapeutics
$1.96 /

+0.065 (+3.43%)

  • 20
    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.